Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases
Hierarchy View
Subtype Terms (26)
Ankylosis
2 drugs (1 approved, 1 experimental)
Arthralgia
59 drugs (33 approved, 26 experimental)
Arthritis
122 drugs (77 approved, 45 experimental)
Arthropathy, Neurogenic
53 drugs (44 approved, 9 experimental)
Bursitis
34 drugs (29 approved, 5 experimental)
Contracture
8 drugs (6 approved, 2 experimental)
Femoracetabular Impingement
11 drugs (7 approved, 4 experimental)
Hallux Rigidus
3 approved drugs
Joint Dislocations
5 approved drugs
Osteoarthropathy, Primary Hypertrophic
1 experimental drug
Osteoarthropathy, Secondary Hypertrophic
Patellofemoral Pain Syndrome
3 drugs (2 approved, 1 experimental)
Shoulder Impingement Syndrome
15 drugs (11 approved, 4 experimental)
Synovitis
24 drugs (23 approved, 1 experimental)
Temporomandibular Joint Disorders
50 drugs (39 approved, 11 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (13)
Phase 3 Indicated Drugs (6)
Phase 2 Indicated Drugs (8)
Phase 1 Indicated Drugs (2)
Organization Involved with Phase 4 Indications (45)
American Association of Hip and Knee Society
American College of Rheumatology Research and Education Foundation
Organization Involved with Phase 3 Indications (17)
Organization Involved with Phase 2 Indications (34)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Dental and Craniofacial Research (NIDCR)
People's Liberation Army of China
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (32)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.